127 related articles for article (PubMed ID: 37031899)
1. Long term results of photodynamic therapy in intraocular tumors.
Karaca BÖ; Türkoğlu EB; Doğan ME
Photodiagnosis Photodyn Ther; 2023 Jun; 42():103564. PubMed ID: 37031899
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic Therapy for Circumscribed Choroidal Hemangioma in 79 Consecutive Patients: Comparative Analysis of Factors Predictive of Visual Outcome.
Di Nicola M; Williams BK; Srinivasan A; Al-Dahmash S; Mashayekhi A; Shields JA; Shields CL
Ophthalmol Retina; 2020 Oct; 4(10):1024-1033. PubMed ID: 32344158
[TBL] [Abstract][Full Text] [Related]
3. PHOTODYNAMIC THERAPY AS PRIMARY TREATMENT FOR SMALL CHOROIDAL MELANOMA.
Turkoglu EB; Pointdujour-Lim R; Mashayekhi A; Shields CL
Retina; 2019 Jul; 39(7):1319-1325. PubMed ID: 29659412
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of subretinal fluid absorption by optical coherence tomography in circumscribed choroidal hemangioma after photodynamic therapy with Verteporfin.
Soucek P; Cihelková I
Neuro Endocrinol Lett; 2004; 25(1-2):109-14. PubMed ID: 15159693
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy with verteporfin for symptomatic circumscribed choroidal hemangioma: five-year outcomes.
Blasi MA; Tiberti AC; Scupola A; Balestrazzi A; Colangelo E; Valente P; Balestrazzi E
Ophthalmology; 2010 Aug; 117(8):1630-7. PubMed ID: 20417564
[TBL] [Abstract][Full Text] [Related]
6. Long term outcome of adjuvant photodynamic therapy after cyberknife radiotherapy for choroidal melanoma.
Turkoglu EB; Rao R; Celik E
Photodiagnosis Photodyn Ther; 2022 Jun; 38():102840. PubMed ID: 35367617
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy with double duration for circumscribed choroidal haemangioma: functional and anatomical results based on initial parameters.
Süsskind D; Inhoffen W; Gelisken F; Völker M
Clin Exp Ophthalmol; 2018 Jul; 46(5):495-501. PubMed ID: 29131474
[TBL] [Abstract][Full Text] [Related]
8. Long-term Outcomes of Small Pigmented Choroidal Melanoma Treated with Primary Photodynamic Therapy.
Roelofs KA; Fabian ID; Arora AK; Cohen VML; Sagoo MS
Ophthalmol Retina; 2021 May; 5(5):468-478. PubMed ID: 32890790
[TBL] [Abstract][Full Text] [Related]
9. Prospective clinical trial evaluating the efficacy of photodynamic therapy for symptomatic circumscribed choroidal hemangioma.
Boixadera A; García-Arumí J; Martínez-Castillo V; Encinas JL; Elizalde J; Blanco-Mateos G; Caminal J; Capeans C; Armada F; Navea A; Olea JL
Ophthalmology; 2009 Jan; 116(1):100-105.e1. PubMed ID: 18973950
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy of circumscribed choroidal hemangioma.
Porrini G; Giovannini A; Amato G; Ioni A; Pantanetti M
Ophthalmology; 2003 Apr; 110(4):674-80. PubMed ID: 12689885
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic Therapy for Choroidal Metastasis.
Ghodasra DH; Demirci H
Am J Ophthalmol; 2016 Jan; 161():104-9.e1-2. PubMed ID: 26432928
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy for symptomatic circumscribed macular choroidal hemangioma in Chinese patients.
Zhang Y; Liu W; Fang Y; Qian J; Xu G; Wang W; Li L; Shen Y; Gao Q
Am J Ophthalmol; 2010 Nov; 150(5):710-715.e1. PubMed ID: 20709311
[TBL] [Abstract][Full Text] [Related]
13. Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: Predisposing Factors for Visual Acuity Outcomes.
Matušková V; Vysloužilová D; Uher M
Semin Ophthalmol; 2018; 33(5):690-699. PubMed ID: 29252091
[TBL] [Abstract][Full Text] [Related]
14. High recurrence rate in patients with choroidal hemangioma treated with limited single spot photodynamic therapy during long-term follow-up.
Stehouwer M; Schlingemann RO; Verbraak FD
Acta Ophthalmol; 2020 Nov; 98(7):679-686. PubMed ID: 32286734
[TBL] [Abstract][Full Text] [Related]
15. DOUBLE FLUENCE PHOTODYNAMIC THERAPY FOR THE TREATMENT OF CIRCUMSCRIBED CHOROIDAL HEMANGIOMA.
Pellegrini M; Staurenghi G; Mambretti M; Preziosa C
Retina; 2022 Apr; 42(4):767-774. PubMed ID: 34861659
[TBL] [Abstract][Full Text] [Related]
16. Circumscribed Choroidal Hemangioma: Visual Outcome in the Pre-Photodynamic Therapy Era versus Photodynamic Therapy Era in 458 Cases.
Shields CL; Dalvin LA; Lim LS; Chang M; Udyaver S; Mazloumi M; Vichitvejpaisal P; Su GL; Florakis E; Mashayekhi A; Shields JA
Ophthalmol Retina; 2020 Jan; 4(1):100-110. PubMed ID: 31611094
[TBL] [Abstract][Full Text] [Related]
17. Comparing efficacy of reduced-fluence and standard-fluence photodynamic therapy in the treatment of polypoidal choroidal vasculopathy.
Ngo WK; Chee WK; Tan CS; Lim TH
BMC Ophthalmol; 2020 Apr; 20(1):150. PubMed ID: 32293353
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy for symptomatic circumscribed choroidal hemangioma in 22 Chinese patients: A retrospective study.
Liu L; Hu C; Chen L; Hu Y
Photodiagnosis Photodyn Ther; 2018 Dec; 24():372-376. PubMed ID: 30381258
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy for symptomatic subretinal fluid related to choroidal nevus.
García-Arumí J; Amselem L; Gunduz K; Badal J; Adan A; Zapata MA; Valldeperas X; Huste F; Corcóstegui B
Retina; 2012 May; 32(5):936-41. PubMed ID: 22366902
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic Therapy for Choroidal Metastasis Tumor Control and Visual Outcomes in 58 Cases: The 2019 Burnier International Ocular Pathology Society Lecture.
Shields CL; Khoo CTL; Mazloumi M; Mashayekhi A; Shields JA
Ophthalmol Retina; 2020 Mar; 4(3):310-319. PubMed ID: 31953111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
